A Homozygous ALCAM–CBLB Deletion at 3q13.11‐q13.12 Defines a Candidate Novel Oculo‐Skeletal‐Immune Contiguous Gene Deletion Syndrome
- 8 October 2026
- journal article
- research article
- Published by Wiley in Clinical Genetics
Abstract
To our knowledge, we report the first combined homozygous deletion of ALCAM and CBLB at 3q13.11‐q13.12. The patient, a 14‐year‐old boy born to consanguineous parents, had a multisystem phenotype with severe congenital ocular and craniofacial anomalies, early‐onset osteoporosis, progressive scoliosis, growth failure, congenital heart defect, humoral immunodeficiency, and chronic inflammatory findings. SNP array identified a 2.5‐Mb homozygous deletion spanning ALCAM and CBLB , and expression studies confirmed complete absence of ALCAM and CBLB expression. Whole‐exome sequencing did not identify an alternative molecular diagnosis. The clinical presentation is likely attributable to combined ALCAM and CBLB loss. Previous animal‐model studies support interpretation of the individual phenotypic components by linking loss of these genes to craniofacial developmental abnormalities, skeletal findings, and immune dysregulation. We propose that this deletion may represent a candidate novel contiguous gene deletion syndrome. This case is the first human phenotype associated with complete ALCAM loss in a contiguous deletion and expands the clinical spectrum associated with disruption of ALCAM and CBLB .Keywords
This publication has 15 references indexed in Scilit:
- Anterior segment dysgenesis: part II—genetics and pathogenesisExpert Review of Ophthalmology, 2024
- Alcam-a and Pdgfr-α are essential for the development of sclerotome-derived stromal cells that support hematopoiesisNature Communications, 2023
- Immunopathogenesis of alopecia areataCurrent Research in Immunology, 2021
- Frizzled 3 acts upstream of Alcam during embryonic eye developmentDevelopmental Biology, 2017
- Alcama mediates Edn1 signaling during zebrafish cartilage morphogenesisDevelopmental Biology, 2011
- Mesenchymal Stem Cells in Perichondrium Express Activated Leukocyte Cell Adhesion Molecule and Participate in Bone Marrow FormationJournal of Experimental Medicine, 2002
- Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-bNature, 2000
- Cbl-b regulates the CD28 dependence of T-cell activationNature, 2000
- Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.Journal of Experimental Medicine, 1995
- Contiguous gene syndromes: A component of recognizable syndromesThe Journal of Pediatrics, 1986